Treatment of a subcapsular renal bleeding after extracorporeal shockwave lithotripsy with recombinant, activated factor VII;Behandlung einer subkapsulären nierenblutung nach extrakorporaler stoßwellenlithotripsie mit rekombinantem faktor VIIa

Anaesthesist

Volumn 51, Issue 11, 2002, Pages 914-917

  Langer, Harald ^a   Strohmaier, W L ^a   Probst, S ^a  

^a Klinikum Coburg gGmbH   (Australia)

Author keywords

Activated factor VII; ESWL; Subcapsular renal bleeding; Treatment of bleeding complications

Indexed keywords

BLOOD CLOTTING FACTOR 8;

ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD TRANSFUSION; CASE REPORT; ERYTHROCYTE CONCENTRATE; EXTRACORPOREAL LITHOTRIPSY; HUMAN; KIDNEY HEMORRHAGE; NEPHRECTOMY;

BLOOD TRANSFUSION; DRAINAGE; ERYTHROCYTE TRANSFUSION; FACTOR VII; HEMATOMA; HEMOSTASIS; HUMANS; KIDNEY DISEASES; LITHOTRIPSY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RECOMBINANT PROTEINS;

EID: 0036857320     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00101-002-0400-z     Document Type: Article

References (16)

1. Bernstein DE, Jeffers L, Erhardtsen E et al. (1997) Recombinant factor VIIa corrects prothrombin time in cirrhotic patients: A preliminary study. Gastroenterology 113:1930-1937
2. Blomback B, Carlsson K, Fatah K, Hessel B, Procyk R (1994) Fibrin in human plasma: Gel architectures governed by rate and nature of fibrinogen activation. Thromb Res 75:521-538
3. Ciavarella N, Schiavoni M,Valenzano E, Mangini F, Inchingolo F (1996) Use of recombinant factor VIIa (NovoSeven®) in the treatment of two patients with type III von Willebrand's disease and an inhibitor against von Willebrand factor. Haemostasis [Suppl 1] 26:150-154
4. Hedner U (1998) Recombinant activated factor VII as a universal haemostatic agent. Blood Coagul Fibrinolysis [Suppl 1] 9:147-152
5. Hoffman M, Monroe DM (2001) A cell-based model of hemostasis. Thromb Haemost 85:958-965
6. Kenet G, Walden R, Eldad A, Martinowitz U (1999) Treatment of traumatic bleeding with recombinant factor VIIa. Lancet 354:1879
7. Kristensen J, Killander A, Hippe E et al. (1996) Clinical experience with recombinant factor VIIa in patients with thrombocytopenia. Haemostasis [Suppl 1] 26:159-164
8. Lusher J, Ingerslev J, Roberts H, Hedner U (1998) Clinical experience with recombinant factor VII. Blood Coagul Fibrinolysis 9:119-128
9. Martin T, Sosa RE (1997) Shock-wave lithotripsy. In: Walsh PE, Retik AB, Vaughan ED, Wein AJ (eds) Campbell's Urology. WB Saunders, Philadelphia, pp 2735-2752
10. Monroe DM, Hoffman M (1998) A possible mechanism of action of activated factor VII independent of tissue factor. Blood Coagul Fibrinolysis [Suppl 1] 9:S15-20
11. Monroe DM, Hoffman M, Oliver JA (1997) Platelet activity of high-dose factor VIIa is independent of tissue factor. Br J Haematol 99:542-547
12. Poon MC, Demmers C, Jobin F, Wu JWY (1999) Recombinant Factor VIIa is effective for bleeding and surgery in patients with Glanzmann disease. Blood 11:3951-3953
13. Scharrer I, Grossmann R (2000) Erworbene Hemmkörperhämophilie. Anaesthesist 49:34-42
14. Strohmaier WL (1995) Potential deleterious effects of shockwave lithotripsy. Curr Opin Urol 5:198-201
15. Vlot AJ,Ton E, Mackaay JC, Kramer MHH, Gaillard CAJM (2000) Treatment of a severly bleeding patient without preexisting coagulopathy with activated recombinant factor VII. Am J Med 108:421-423
16. White B, McHale J, Ravi N, Reynolds J, Stephens R, Moriarty J, Smith OP (1999) Successful use of recombinant FVIIa (Novoseven) in the management of intractable post-surgical intra-abdominal haemorrhage. Br J Hematol 107:677-687